Zimmer Biomet Announces Second Quarter 2021 Financial Results

Go back to Zimmer Biomet Announces Second Quarter 2021 Financial Results

Zimmer Biomet (ZBH) PT Raised to $197 at Baird

August 4, 2021 9:02 AM EDT

Baird analyst Jeffrey Johnson raised the price target on Zimmer Biomet (NYSE: ZBH) to $197.00 (from $195.00) while maintaining an Outperform rating.

The analyst commented, "A few issues weighed on shares yesterday, including China tender and ZBH market share uncertainties and somewhat sluggish pace of... More

Zimmer Biomet Holdings (ZBH) Tops Q2 EPS by 3c

August 3, 2021 6:35 AM EDT

Zimmer Biomet Holdings (NYSE: ZBH) reported Q2 EPS of $1.90, $0.03 better than the analyst estimate of $1.87. Revenue for the quarter came in at $2.03 billion versus the consensus estimate of $1.98 billion.

"Our performance in the second quarter improved meaningfully from the first quarter 2021 across all... More